IPP Bureau
Biocon - Generics & research grow; biosimilar stagnates - ICICI Securities
By IPP Bureau - May 26, 2022
ICICI Direct expects revenue CAGR of 35.6% over FY22-FY24E mainly due to the consolidation of Viatris business and they expect EBITDA margin expansion of 230bps and earnings CAGR of 64.8% over FY22-FY24E
Honeywell and Narayana Health partner to explore co-creation of healthcare technologies
By IPP Bureau - May 26, 2022
Strategic partnership will develop a digital transformation roadmap and create opportunities for co-innovation in healthcare technologies
Lumenis OptiLight wins 2022 MedTech Breakthrough Award
By IPP Bureau - May 26, 2022
For the third straight year, Lumenis wins an award recognizing outstanding medical companies and technologies
ASG Eye Hospitals opens unit in Dombivli, Maharashtra
By IPP Bureau - May 26, 2022
The new facility at Dombivli is the fifth ASG Eye Hospital in Maharashtra
Strides Pharma Science Q4FY22 consolidated PAT at Rs. 29.21 Cr
By IPP Bureau - May 26, 2022
The company has posted net loss of Rs. 460.21 crores for the Financial Year ended March 31, 2022.
Pristyn Care announces ‘CARES’ initiative
By IPP Bureau - May 26, 2022
Five patient-first principles to provide the highest standard of healthcare
Eugia Pharma receives USFDA approval for Pemetrexed
By IPP Bureau - May 26, 2022
Pemetrexed for injection is indicated for the treatment of Antineoplastics (medications used to treat cancer)
Zydus Lifesciences receives final approval from USFDA for Pemetrexed for Injection
By IPP Bureau - May 26, 2022
Pemetrexed for Injection has a market size of USD 1,236 mn (as per IQVIA MAT March’22)
Dr. Reddy's and Senores Pharmaceuticals launches Ketorolac Tromethamine tablets in the U.S. market
By IPP Bureau - May 25, 2022
The Toradol tablets, 10 mg brand and generic had U.S. sales of approximately US $ 16.8 million MAT for the most recent twelve months ending in March 2022 according to IQVIA
Borrena approval strengthens Pfizer position in China NSCLC market: GlobalData
By IPP Bureau - May 25, 2022
According to GlobalData’s ‘Pharmaceutical Intelligence Center’, the number of diagnosed prevalent cases of ALK-mutant NSCLC in China is estimated to grow at a CAGR of 5.3% from 22,725 in 2021 to 31,902 in 2029
Cipla scored highest among pharma companies in CRISIL’s Sustainability Rating 2022
By IPP Bureau - May 25, 2022
By 2025, the company plans to achieve carbon and water neutrality, zero-waste to landfill, anti-microbial resistance stewardship and green chemistry
Lonza partners with Israel Biotech Fund to support biologics and small molecules development
By IPP Bureau - May 25, 2022
The two-year agreement will grant Lonza access to IBF's prominent network and allow IBF to benefit from Lonza's manufacturing expertise and knowledge in its due diligence review of potential targets
European Commission approves Keytruda plus chemotherapy as neoadjuvant treatment for breast cancer
By IPP Bureau - May 25, 2022
This Keytruda combination is the first immunotherapy option approved in the EU for high-risk early-stage TNBC
ENPICOM launches versatile display data analysis solution to accelerate antibody selection
By IPP Bureau - May 25, 2022
The new IGX-Track App adds seamless analysis of antibody panning campaigns to the IGX Platform
Fitelo unveils new branding after Pre-Series A fund-raise
By IPP Bureau - May 25, 2022
Each member of Fitelo's team of experts gives highly personalized attention and recommendations to their clients ensuring they reach their fitness goals holis
